POINT Biopharma Global Price on May 20, 2024

PNTDelisted Stock  USD 9.06  0.10  1.09%   
If you're considering investing in POINT Stock, it is important to understand the factors that can impact its price. As of today, the current price of POINT Biopharma stands at 9.06, as last reported on the 1st of December, with the highest price reaching 9.16 and the lowest price hitting 8.86 during the day. We have found twenty-nine technical indicators for POINT Biopharma Global, which you can use to evaluate the volatility of the company. Please check POINT Biopharma's risk adjusted performance of 0.0612, and Semi Deviation of 2.58 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
POINT Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PNT
Based on monthly moving average POINT Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of POINT Biopharma by adding POINT Biopharma to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About POINT Biopharma Stock history

POINT Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for POINT is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in POINT Biopharma Global will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing POINT Biopharma stock prices may prove useful in developing a viable investing in POINT Biopharma
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana. Point Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.

POINT Biopharma Stock Technical Analysis

POINT Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of POINT Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of POINT Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

POINT Biopharma Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

POINT Biopharma Global cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

POINT Biopharma December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how POINT Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading POINT Biopharma shares will generate the highest return on investment. By undertsting and applying POINT Biopharma stock market strength indicators, traders can identify POINT Biopharma Global entry and exit signals to maximize returns

POINT Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for POINT Biopharma's price direction in advance. Along with the technical and fundamental analysis of POINT Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of POINT to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in POINT Stock

If you are still planning to invest in POINT Biopharma Global check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the POINT Biopharma's history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stocks Directory
Find actively traded stocks across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities